Malaysian Obesity Society

06/01/2026

Unregulated and compounded “weight-loss injections” are increasingly being sold online, raising serious concerns about safety, quality, and lack of medical oversight. Some products may not even contain the claimed active ingredient. MYOS supports improved access to evidence-based obesity care, but this must be done safely and responsibly.

Read our full statement and learn how to protect yourself at our website now!

Founded in late 2022, the Malaysian Obesity Society (MYOS) is a non-profit professional community for healthcare and allied health practitioners in Malaysia. United by a shared mission to enhance obesity care, MYOS focuses on advancing clinical practice, raising awareness, and sharing expertise to i...

01/01/2026

Happy New Year from MYOS. May 2026 be a year of health, clarity and joy to all!

See you at our National Obesity Scientific Conference 2026 at CECC, Kuala Lumpur om 11-12 April 2026!

01/01/2026

01/01/2026

Happy 2026!

30/12/2025

2025 has been an exciting year for obesity treatment.

Let us not forget it is our patient at the center of obesity management.

09/11/2025

There's science behind weight recurrence.

Research shows that 80 to 95 percent of people who lose weight regain it within three to five years. Scientists say that’s not a failure of willpower. Hormones, genetics, and even evolution push the body to fight back—driving hunger up, slowing metabolism, and urging the pounds to return. Here’s how researchers say we can work with our bodies, not against them: https://on.natgeo.com/49qKfg7

08/11/2025

On the cover this week, a new analysis of the SELECT trial confirms semaglutide lowers the risk of major heart problems in people who are overweight or obese and already have heart disease, even if they don’t have diabetes.

Read this & more in the latest issue, link in comments 👇

08/11/2025

The benefit of Obesity Medication Management (OMM) goes beyond the weight loss!

On the cover this week, a new analysis of the SELECT trial confirms semaglutide lowers the risk of major heart problems in people who are overweight or obese and already have heart disease, even if they don’t have diabetes.

Read this & more in the latest issue, link in comments 👇

03/11/2025

MYOS is excited to be at INSPEN, Kajang, Selangor, today to collaborate with Ministry of Health in organizing the Training of Trainers (ToT) of the Multidisciplinary Integrated Management of Obesity (MIMO) that is to be rolled out very soon.

Prof Nisak, Dr Ariff Fahmi and Dr Masni shared on the different aspects of management of obesity, backed by strong scientific basis, clinical experience, and real-life examples.

We are very encouraged by the support by MoH, the strong attendance and response by the healthcare professionals from around the country who are earmarked as leaders in their respective institutions to conduct integrated obesity care in their settings.

We are optimistic that this will be a catalyst for improvement of clinical obesity care nationwide in the near future 💪🏽

24/10/2025

Liver health is an often overlooked imperative.

A blog by The Public Health Liver Group at the Barcelona Institute for Global Health (ISGlobal).

12/10/2025

📣 CALLING FOR ABSTRACTS!

The 2nd National Obesity Scientific Meeting (NOSM 2026) is now open for abstract submissions!
Join us and share your research, ideas, and innovations in obesity science. Don’t miss the chance to be one of our Oral Presenters! 🌟

📍 Event Details:
🗓️ 11th – 12th April 2026
📌 Connexion Conference & Event Centre, Kuala Lumpur, Malaysia

🔗 Scan the QR code on the poster or visit our conference website below to submit your abstract(s)!
https://myosconference.com/

06/10/2025

🇲🇾 Malaysia’s SSB Tax — 5 Years On 🍹💰

Less sugar, more awareness — but room to grow.

The Ministry of Health Malaysia (MOH) KEMENTERIAN KESIHATAN MALAYSIA and UNICEF evaluated Malaysia’s sugar-sweetened beverage (SSB) tax, introduced in 2019 to curb obesity and NCDs.

🔍 Key findings:
• 💸 Retail prices rose only 2.2%, below the expected 8.3%, as producers absorbed costs or reformulated drinks.
• 🧃 More “Healthier Choice” products now on shelves — showing industry reformulation works.
• 📉 SSB consumption dropped (16.4% drank carbonated drinks monthly vs 36.9% in 2017 NHMS).
• ⚠️ Low awareness: only 1 in 4 adolescents and 1 in 3 parents knew about the tax.
• 💼 No job loss or major business impact; large producers adapted faster than SMEs.
• 💰 RM198.6 million revenue collected (2020–2022) — but funds are not earmarked for health programmes.

🔑 Recommendations:
1. Raise the tax rate and tighten enforcement.
2. Support SMEs to produce healthier beverages.
3. Earmark tax revenue for health and nutrition programmes.
4. Enhance public education and target rural & B40 communities.
5. Restrict marketing of unhealthy drinks to children.

⸻

🩺 The SSB tax works — but to make Malaysians truly healthier, it needs stronger rates, better communication, and visible reinvestment into health.